瘤中ALKBH5和读者蛋白之间的相互作用:功能和分子机制
Jiahui Ou1, Bingchen Liu1, Yi Yu1
1School of Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Frontiers in oncology
|September 17, 2025
概括
不调节的RNA脱甲基酶ALKBH5和m6A读者蛋白通过改变mRNA生物学来影响瘤进展. 准这些蛋白质为新的抗瘤药物开发提供了潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- N6-甲基氨酸 (m6A) 是真核生物中最常见的mRNA修饰.
- RNA脱甲基酶ALKBH5的失调与瘤研究有关.
- ALKBH5 与m6A读者蛋白相互作用,影响mRNA处理和稳定性.
研究的目的:
- 审查ALKBH5和m6A读者蛋白质的结构.
- 总结它们在瘤发生中的合作调节机制.
- 探索它们作为抗瘤药物开发目标的潜力.
主要方法:
- 结构和功能研究的文献综述.
- 合作性监管机制的分析.
- 针对ALKBH5和读者蛋白的临床前和临床数据的摘要.
主要成果:
- ALKBH5和m6A读者蛋白在调节mRNA命运方面发挥着至关重要的作用.
- 它们的失调有助于各种癌症的发展.
- 了解它们的相互作用是解读瘤进展的关键.
结论:
- ALKBH5和m6A读者蛋白是癌症中的关键调节者.
- 准这些蛋白质为新型癌症疗法提供了一个有希望的途径.
- 进一步的研究可以为推进抗瘤策略提供坚实的基础.
相关概念视频
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


